Review of pharmacotherapy for smoking cessation in patients with schizophrenia
Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The purpose of this article is to provide a nonsystematic review of the efficacy of smoking cessation interventions as well as to...
Gespeichert in:
| Veröffentlicht in: | The mental health clinician 2018-03, Vol.8 (2), p.78-85 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 85 |
|---|---|
| container_issue | 2 |
| container_start_page | 78 |
| container_title | The mental health clinician |
| container_volume | 8 |
| creator | Shawen, Avery E Drayton, Shannon J |
| description | Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The purpose of this article is to provide a nonsystematic review of the efficacy of smoking cessation interventions as well as to explore the potential neuropsychiatric adverse effects of these agents in patients with schizophrenia. Eighteen studies were found and included in the review. Overall, nicotine replacement therapy, bupropion, and varenicline have all proven their effectiveness at either promoting smoking abstinence or a significant reduction in cigarette use. |
| doi_str_mv | 10.9740/mhc.2018.03.078 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6007740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2062827729</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2388-92ba5028d72c107ef457d5c639dd8633d547cab8ff178caa28fae5807beef3df3</originalsourceid><addsrcrecordid>eNpVUU1LAzEQDaLYUnv2Jjl66XY26W6yF0GKX1AURM8hzSbdaHezJtuW-utNqZY6lxmYN28e7yF0mUJSsAmM60olBFKeAE2A8RPUJ2nORwWD4vRo7qFhCB8AELGTLC_OUY8URRYL-uj5Va-t3mBncFtJX0vlukp72W6xcR6H2n3aZoGVDkF21jXYNriNk266gDe2q3BQlf12beV1Y-UFOjNyGfTwtw_Q-_3d2_RxNHt5eJrezkaKUB5lkbnMgPCSEZUC02aSsTJTOS3KkueUltmEKTnnxqSMKykJN1JnHNhca0NLQwfoZs_brua1LlWU4-VStN7W0m-Fk1b83zS2Egu3FjkAi95FgutfAu--Vjp0orZB6eVSNtqtgiCQE04YI0WEjvdQ5V0IXpvDmxTELggRgxC7IARQEYOIF1fH6g74P9vpD5fkhwA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2062827729</pqid></control><display><type>article</type><title>Review of pharmacotherapy for smoking cessation in patients with schizophrenia</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Shawen, Avery E ; Drayton, Shannon J</creator><creatorcontrib>Shawen, Avery E ; Drayton, Shannon J</creatorcontrib><description>Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The purpose of this article is to provide a nonsystematic review of the efficacy of smoking cessation interventions as well as to explore the potential neuropsychiatric adverse effects of these agents in patients with schizophrenia. Eighteen studies were found and included in the review. Overall, nicotine replacement therapy, bupropion, and varenicline have all proven their effectiveness at either promoting smoking abstinence or a significant reduction in cigarette use.</description><identifier>ISSN: 2168-9709</identifier><identifier>EISSN: 2168-9709</identifier><identifier>DOI: 10.9740/mhc.2018.03.078</identifier><identifier>PMID: 29955550</identifier><language>eng</language><publisher>United States: College of Psychiatric & Neurologic Pharmacists</publisher><subject>Review of Pharmacotherapy</subject><ispartof>The mental health clinician, 2018-03, Vol.8 (2), p.78-85</ispartof><rights>2018 CPNP. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2388-92ba5028d72c107ef457d5c639dd8633d547cab8ff178caa28fae5807beef3df3</citedby><cites>FETCH-LOGICAL-c2388-92ba5028d72c107ef457d5c639dd8633d547cab8ff178caa28fae5807beef3df3</cites><orcidid>0000-0001-5957-2642 ; 0000-0002-6634-918X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007740/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007740/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29955550$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shawen, Avery E</creatorcontrib><creatorcontrib>Drayton, Shannon J</creatorcontrib><title>Review of pharmacotherapy for smoking cessation in patients with schizophrenia</title><title>The mental health clinician</title><addtitle>Ment Health Clin</addtitle><description>Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The purpose of this article is to provide a nonsystematic review of the efficacy of smoking cessation interventions as well as to explore the potential neuropsychiatric adverse effects of these agents in patients with schizophrenia. Eighteen studies were found and included in the review. Overall, nicotine replacement therapy, bupropion, and varenicline have all proven their effectiveness at either promoting smoking abstinence or a significant reduction in cigarette use.</description><subject>Review of Pharmacotherapy</subject><issn>2168-9709</issn><issn>2168-9709</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVUU1LAzEQDaLYUnv2Jjl66XY26W6yF0GKX1AURM8hzSbdaHezJtuW-utNqZY6lxmYN28e7yF0mUJSsAmM60olBFKeAE2A8RPUJ2nORwWD4vRo7qFhCB8AELGTLC_OUY8URRYL-uj5Va-t3mBncFtJX0vlukp72W6xcR6H2n3aZoGVDkF21jXYNriNk266gDe2q3BQlf12beV1Y-UFOjNyGfTwtw_Q-_3d2_RxNHt5eJrezkaKUB5lkbnMgPCSEZUC02aSsTJTOS3KkueUltmEKTnnxqSMKykJN1JnHNhca0NLQwfoZs_brua1LlWU4-VStN7W0m-Fk1b83zS2Egu3FjkAi95FgutfAu--Vjp0orZB6eVSNtqtgiCQE04YI0WEjvdQ5V0IXpvDmxTELggRgxC7IARQEYOIF1fH6g74P9vpD5fkhwA</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Shawen, Avery E</creator><creator>Drayton, Shannon J</creator><general>College of Psychiatric & Neurologic Pharmacists</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5957-2642</orcidid><orcidid>https://orcid.org/0000-0002-6634-918X</orcidid></search><sort><creationdate>201803</creationdate><title>Review of pharmacotherapy for smoking cessation in patients with schizophrenia</title><author>Shawen, Avery E ; Drayton, Shannon J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2388-92ba5028d72c107ef457d5c639dd8633d547cab8ff178caa28fae5807beef3df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Review of Pharmacotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shawen, Avery E</creatorcontrib><creatorcontrib>Drayton, Shannon J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The mental health clinician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shawen, Avery E</au><au>Drayton, Shannon J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of pharmacotherapy for smoking cessation in patients with schizophrenia</atitle><jtitle>The mental health clinician</jtitle><addtitle>Ment Health Clin</addtitle><date>2018-03</date><risdate>2018</risdate><volume>8</volume><issue>2</issue><spage>78</spage><epage>85</epage><pages>78-85</pages><issn>2168-9709</issn><eissn>2168-9709</eissn><abstract>Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The purpose of this article is to provide a nonsystematic review of the efficacy of smoking cessation interventions as well as to explore the potential neuropsychiatric adverse effects of these agents in patients with schizophrenia. Eighteen studies were found and included in the review. Overall, nicotine replacement therapy, bupropion, and varenicline have all proven their effectiveness at either promoting smoking abstinence or a significant reduction in cigarette use.</abstract><cop>United States</cop><pub>College of Psychiatric & Neurologic Pharmacists</pub><pmid>29955550</pmid><doi>10.9740/mhc.2018.03.078</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5957-2642</orcidid><orcidid>https://orcid.org/0000-0002-6634-918X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-9709 |
| ispartof | The mental health clinician, 2018-03, Vol.8 (2), p.78-85 |
| issn | 2168-9709 2168-9709 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6007740 |
| source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Review of Pharmacotherapy |
| title | Review of pharmacotherapy for smoking cessation in patients with schizophrenia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A24%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20pharmacotherapy%20for%20smoking%20cessation%20in%20patients%20with%20schizophrenia&rft.jtitle=The%20mental%20health%20clinician&rft.au=Shawen,%20Avery%20E&rft.date=2018-03&rft.volume=8&rft.issue=2&rft.spage=78&rft.epage=85&rft.pages=78-85&rft.issn=2168-9709&rft.eissn=2168-9709&rft_id=info:doi/10.9740/mhc.2018.03.078&rft_dat=%3Cproquest_pubme%3E2062827729%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2062827729&rft_id=info:pmid/29955550&rfr_iscdi=true |